ZyVersa Therapeutics News

Buy Rating Affirmed: ZyVersa Therapeutics' Promising Pipeline and Strategic Advancements

TipRanksMar 26 06:25 ET

ZyVersa Therapeutics Analyst Ratings

BenzingaMar 26 06:17 ET

Zyversa Therapeutics' 1-for-35 Reverse Split: Navigating the Risks to Shareholder Value and Liquidity

TipRanksMar 26 02:05 ET

ZyVersa Therapeutics Analyst Ratings

BenzingaMar 12 08:24 ET

Analysts Are Bullish on Top Healthcare Stocks: ACELYRIN, INC. (SLRN), ZyVersa Therapeutics (ZVSA)

TipRanksMar 12 06:35 ET

Buy Rating Affirmed for ZyVersa Therapeutics Amid Promising Inflammatory and Metabolic Syndrome Treatments

TipRanksFeb 29 06:46 ET

HC Wainwright & Co. Initiates Coverage On ZyVersa Therapeutics With Buy Rating, Announces Price Target of $2.5

BenzingaSep 8, 2023 06:59 ET

ZyVersa Therapeutics Analyst Ratings

BenzingaSep 8, 2023 06:58 ET

Analysts Offer Insights on Healthcare Companies: ZyVersa Therapeutics (ZVSA), Halozyme (HALO) and Nurix Therapeutics (NRIX)

TipRanksSep 8, 2023 06:20 ET